#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Mother–Infant HIV Transmission: Do Maternal HIV-Specific Antibodies Protect the Infant?


article has not abstract


Vyšlo v časopise: Mother–Infant HIV Transmission: Do Maternal HIV-Specific Antibodies Protect the Infant?. PLoS Pathog 10(8): e32767. doi:10.1371/journal.ppat.1004283
Kategorie: Pearls
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004283

Souhrn

article has not abstract


Zdroje

1. LehmanDA, FarquharC (2007) Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 17: 381–403 doi:10.1002/rmv.543

2. TobinNH, AldrovandiGM (2013) Immunology of pediatric HIV infection. Immunol Rev 254: 143–169 doi:10.1111/imr.12074

3. UNAIDS (2013) Global Report: UNAIDS report on the global AIDS epidemic 2013. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/unaids_global_report_2013_en.pdf. Accessed 22 July 2014.

4. MilliganC, OverbaughJ (2014) The Role of Cell-Associated Virus in Mother-to-Child HIV Transmission. J Infect Diseases In press.

5. ChiBH, StringerJSA, MoodleyD (2013) Antiretroviral Drug Regimens to Prevent Mother-To-Child Transmission of HIV: A Review of Scientific, Program, and Policy Advances for Sub-Saharan Africa. Curr HIV/AIDS Rep 10: 124–133 doi:10.1007/s11904-013-0154-z

6. ParedesR, MarconiVC, AbramsEJ, LockmanS, KuhnL (2013) Impact of Antiretroviral Drugs in Pregnant Women and Their Children in Africa: HIV Resistance and Treatment Outcomes. J Infect Diseases 207 Suppl 2: S93–S100 doi:10.1093/infdis/jit110

7. LehmanDA, John-StewartGC, OverbaughJ (2009) Antiretroviral strategies to prevent mother-to-child transmission of HIV: striking a balance between efficacy, feasibility, and resistance. PLoS Med 6: e1000169 doi:10.1371/journal.pmed.1000169

8. ScarlattiG, AlbertJ, RossiP, HodaraV, BiraghiP, et al. (1993) Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis 168: 207–210.

9. KliksSC, WaraDW, LandersDV, LevyJA (1994) Features of HIV-1 that could influence maternal-child transmission. JAMA 272: 467–474.

10. DickoverR, GarrattyE, YusimK, MillerC, KorberB, et al. (2006) Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants. J Virol 80: 6525–6533 doi:10.1128/JVI.02658-05

11. BaanE, De RondeA, StaxM, SandersRW, LuchtersS, et al. (2013) HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission. PLoS ONE 8: e69274 doi:10.1371/journal.pone.0069274.t002

12. BarinF, JourdainG, BrunetS, Ngo-Giang-HuongN, WeerawatgoompaS, et al. (2006) Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1. J Infect Dis 193: 1504–1511 doi:10.1086/503778

13. BurtonDR, StanfieldRL, WilsonIA (2005) Antibody vs. HIV in a clash of evolutionary titans. Proc Natl Acad Sci U S A 102: 14943–14948 doi:10.1073/pnas.0505126102

14. LynchJB, NduatiR, BlishCA, RichardsonBA, MabukaJM, et al. (2011) The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection. J Virol 85: 5252–5261 doi:10.1128/JVI.02216-10

15. OmendaMM, MilliganC, Odem-DavisK, NduatiR, RichardsonB, et al. (2013) Evidence for Efficient Vertical Transfer of Maternal HIV-1 Envelope-Specific Neutralizing Antibodies but No Association of Such Antibodies with Reduced Infant Infection. J Acquir Immune Defic Syndr 64: 163–166 doi:10.1097/QAI.0b013e31829f6e41

16. WuX, ParastAB, RichardsonBA, NduatiR, John-StewartG, et al. (2006) Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol 80: 835–844 doi:10.1128/JVI.80.2.835-844.2006

17. ZhangH, RolaM, WestJT, TullyDC, KubisP, et al. (2010) Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission. Virology 400: 164–174 doi:10.1016/j.virol.2009.12.019

18. GooL, MilliganC, SimonichCA, NduatiR, OverbaughJ (2012) Neutralizing Antibody Escape during HIV-1 Mother-to-Child Transmission Involves Conformational Masking of Distal Epitopes in Envelope. J Virol 86: 9566–9582 doi:10.1128/JVI.00953-12

19. JulienJ-P, CupoA, SokD, StanfieldRL, LyumkisD, et al. (2013) Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342: 1477–1483 doi:10.1126/science.1245625

20. MabukaJ, NduatiR, Odem-DavisK, PetersonD, OverbaughJ (2012) HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads. PLoS Pathog 8: e1002739 doi:10.1371/journal.ppat.1002739

21. Van de PerreP (2003) Transfer of antibody via mother's milk. Vaccine 21: 3374–3376.

22. HaynesBF, GilbertPB, McElrathMJ, Zolla-PaznerS, TomarasGD, et al. (2012) Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 366: 1275–1286 doi:10.1056/NEJMoa1113425

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2014 Číslo 8
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#